Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$2.32 USD
-0.07 (-2.93%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Adverum Biotechnologies, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ADVM 2.32 -0.07(-2.93%)
Will ADVM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADVM
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates
Adverum Biotechnologies (ADVM) Upgraded to Strong Buy: What Does It Mean for the Stock?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
Bet on 5 Top-Ranked Stocks With Rising P/E
Wall Street Analysts See a 332.28% Upside in Adverum Biotechnologies (ADVM): Can the Stock Really Move This High?
Other News for ADVM
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
Adverum Biotechnologies price target lowered to $12 from $16 at Mizuho
Adverum Biotechnologies price target lowered by $4 at Mizuho, here's why
Mizuho Securities Sticks to Their Buy Rating for Adverum Biotechnologies (ADVM)